DALLAS, July 31, 2014 /PRNewswire/ --
Clinical Decision Support System (CDSS) Market [Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), (Hardware, Software)] - Global Forecast to 2018 is a 242 pages premium business intelligence research providing industry analysis and information on major players around the world. The market is segmented based on products, models, applications, delivery modes, components, and provider entity capacity. Based on products, the CDSS market is further segmented into integrated and standalone CDSS solutions. Of all the integrated solutions (EHR-CDSS, EHR-CDSS-CPOE, and CDSS-CPOE), EHR-CDSS-CPOE will be the fastest-growing market in the next five years. Factors accelerating the growth of this market are the presence of government initiatives to promote clinical IT solutions such as EHR, CDSS, and CPOE; growing pressure to curtail healthcare costs; and rising demand for quality care. Integrated CDSS solutions also help in reducing the incidences of medication errors and facilitate the easier integration of clinical data repositories with workflow systems.
Based on applications, the CDSS market [http://www.lifescienceindustryresearch.com/clinical-decision-support-system-cdss-market-product-integrated-ehr-cpoe-model-knowledge-based-applications-drug-allergy-alerts-drug-interactions-delivery-mode-web-based-cloud-based.html ] is segmented into drug allergy alerts, drug reminders, drug-drug interactions, clinical guidelines, clinical reminders, drug dosing support, and others. Drug allergy alerts accounted for the largest share of the global CDSS market in 2013. On the other hand, clinical reminders are expected to witness the highest growth at an estimated double-digit CAGR from 2013 to 2018. Various benefits while implementing this system, such as just-in-time alerts, prompt recommendation at the point-of-care, and improvements in quality care at low costs, will spur the market growth.
The three most important delivery modes considered for the study are web-based, on-premises, and cloud computing. Owing to the growing need to meet the requirement of enhanced security and accessibility, the cloud computing mode of delivery is expected to grow at a brisk pace in the forecast period (2013-2018). Furthermore, cloud computing also reduces the burden on healthcare systems, as the need for an IT staff is eliminated.
Companies profiled in this clinical decision support system market report include Cerner Corporation, Elsevier B.V., EPIC, IBM Corporation, McKesson Corporation, Medical Information Technology, Inc. (Meditech), Philips Healthcare, Siemens Healthcare, Wolters Kluwer Health and Zynx Health. Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=19258 . The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the CDSS market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Geographic analysis reveals that North America was the largest contributor to the global clinical decision support system market in 2013 and will also be the fastest growing region for CDSS till 2018. Factors driving the North American market are the growing demands for integrated CDSS solution with EHR and CPOE, firm support from the U.S. Agency for Healthcare Research and Quality (AHRQ), growth in aging population, growing healthcare cost, and growth in patient consumerism for quality care. Countries such as China, India, Singapore, and Australia will also offer potential growth opportunities to CDSS stakeholders. Saudi Arabia and Brazil will also emerge as lucrative markets for CDSS vendors. In Saudi Arabia, various favorable government initiatives are focusing on strengthening healthcare services such as the e-Health program. The e-Health projects are aligned with the predefined goals of the Ministry of Health, which has made it mandatory to implement Information Communication Technology (ICT) in the country's healthcare system. Similarly, the Brazilian government has launched a series of initiatives such as Prosoft, and Lei-de-Informatica and Renuncia Fiscal, to foster and promote clinical IT solutions. Improving financial support from government, coupled with various initiatives, is a significant factor providing impetus to the CDSS market growth.
Globally, the CDSS market will be driven by the growing pressure to reduce healthcare costs, growing patient consumerism for quality care, rising demand for analytical solutions, and government initiatives that promote the adoption of CDSS. The major bottlenecks for this market are the growing concerns over security, interoperability, integration challenges, costs incurred while integrating, problems in implementing CDSS solutions, alert fatigue, incomplete or poor quality of data entry, poor IT skills among staff, and poor financial support from governments in certain countries in Europe and Asia. Cloud computing models offer huge growth opportunities for CDSS vendors, globally. Also, large sized hospitals (>300 bed size) will be potential growth segments for CDSS companies in the coming years.
Comprehensive Table of Contents and List of data tables and figures provided in Clinical Decision Support System (CDSS) Market [Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), (Hardware, Software)] - Global Forecast to 2018 research report are available at http://www.lifescienceindustryresearch.com/clinical-decision-support-system-cdss-market-product-integrated-ehr-cpoe-model-knowledge-based-applications-drug-allergy-alerts-drug-interactions-delivery-mode-web-based-cloud-based.html#tabs-2 .
Healthcare EDI Market by Component (EDI Software, EDI Services), Transactions (Claim Status, Eligibility Verification), Mode of Delivery (Web-based EDI, Mobile EDI, EDI Van) & by End-users (Healthcare Payers, Providers) - Global Forecast to 2018 is a 215 pages research report published in May 2014. It says the market is expected to grow at a CAGR of 13.7% from 2013 to 2018 to reach $1,681.1 million by 2018. Major companies profiled and discussed in this report include Emdeon Inc. (U.S.), Allscripts (U.S.), Mckesson (U.S.), Optum Health (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), SSI Group (U.S.), ZirMed (U.S.), Passport Health communications (U.S.), and Capario (U.S.). Complete report is available at http://www.lifescienceindustryresearch.com/healthcare-edi-market-by-component-edi-software-edi-services-transactions-claim-status-eligibility-verification-mode-of-delivery-web-based-edi-mobile-edi-edi-van-by-end-users-healthcare.html .
Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) is a March 2014 publication of 195 pages. It says, in 2013, Europe was the largest market for pharmaceutical membrane filtration. However, the North American market is expected to grow rapidly in the forecast period between 2013 and 2018 and is expected to be as large as that of Europe by 2018. Companies profiled in this research include 3M, Alfa Laval, GE, GEA Group, Graver Technologies, Koch Membrane Systems, Meco, Merck Millipore, Novasep, Pall Corporation, Sartorius Stedim Biotech and Spectrum Laboratories. Read more at http://www.lifescienceindustryresearch.com/pharmaceutical-membrane-filtration-market-by-technology-microfiltration-ultra-filtration-nan-filtration-reverse-osmosis-ion-exchange-application-cell-separation-protein-purification-sterili.html .
Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018 is a July 2014 publication spread across 252 pages. The major players in this market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Read more at http://www.lifescienceindustryresearch.com/digital-pathology-market-slide-scanners-whole-slide-imaging-analytics-image-analysis-software-delivery-modes-web-based-cloud-based-and-whole-slide-image-storage-global-trends-forecast-t.html .
Explore more reports on healthcare market at http://www.lifescienceindustryresearch.com/category/healthcare .
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories. Contact us (firstname.lastname@example.org / + 1 888 391 5441) for any of your research requirements or topics of interest. Our sales & research associates will be happy to help you find relevant market data.
TX, Dallas North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas 75252
Tel: +1-888-391-5441 email@example.com
Connect With Us on:
G+ / Google Plus: https://plus.google.com/112612135957880308475/about
RSS Feed: http://www.lifescienceindustryresearch.com/feed